Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
When blood cancer starts to spread, tumor cells diversify and affect immune response
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...
EurekAlert!1d
When blood cancer starts to spread
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...
Medscape1d
Anticoagulants No More Dangerous Than Aspirin for Bleeds: Annals
Some clinicians prefer aspirin when balancing bleeding risk with the indication for an anticoagulant, Barnes said, reasoning ...